Fig. 2From: Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific mannerEngineered OAV-based gene delivery platform. Representatives of OAV modifications are depicted. Strategies of OAV replication and entry include the E1A∆24, ΔE1A 13S CR3, ΔE1B55K and specific promoter regulation of E1A as well as capsid modificationBack to article page